RVMD

REVOLUTION MEDICINES INC

Healthcare | Mid Cap

-$1.38

EPS Forecast

$8.23

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
BCRXBiocryst Pharmaceuticals IncPLXProtalix Biotherapeutics IncRGNXRegenxbio IncVCELVericel CorpVIRVir Biotechnology IncRLAYRelay Therapeutics Inc